Lysoclear
Lafayette
About Lysoclear
Lysoclear, Inc. is a pre-clinical Ichor Therapeutics portfolio company that develops enzyme therapies for eye disease. The company is currently developing leads to treat atrophic “dry” age-related macular degeneration and Stargardt’s macular degeneration.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.0M
- Last round: Series Unknown (Dec 2018)
- Website: lysoclear.com
- Phone: (518) 420-5004
Industries & Categories
Biotechnology, Life Science
Canonical: https://fsome.com/organization/lysoclear-125197 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.